✦ LIBER ✦

1136 Pharmacokinetics in the early period after sunitinib treatment predict adverse events and clinical outcome of patients with advanced renal cell carcinoma

✍ Scribed by Takayama, K.; Tsuchiya, N.; Narita, S.; Inoue, T.; Saito, M.; Numakura, K.; Tsuruta, H.; Huang, M.; Satoh, S.; Habuchi, T.

Book ID: 122215247
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 986 KB
Volume: 13
Category: Article
ISSN: 1569-9056
DOI: 10.1016/S1569-9056(14)61116-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1100 Association of pharmacokinetics of

1100 Association of pharmacokinetics of sunitinib with treatment outcome and adverse events in advanced renal cell carcinoma patients

✍ Tsuchiya, N.; Fujiyama, N.; Narita, S.; Inoue, T.; Numakura, K.; Akihama, S.; Sa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 152 KB

1839 EVALUATING THE ASSOCIATION AMONG TH

1839 EVALUATING THE ASSOCIATION AMONG THE PHARMACOKINETICS OF SUNITINIB, ITS ADVERSE EVENTS AND THE TREATMENT OUTCOMES IN ADVANCED RENAL CELL CARCINOMA

✍ Tsuchiya, Norihiko; Fujiyama, Nobuhiro; Narita, Shintaro; Inoue, Takamitsu; Numa 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 119 KB

7136 POSTER The Association Between Trea

7136 POSTER The Association Between Treatment (tx) Modifications Due to Adverse Events (AEs) and Overall Survival (OS) in Patients (pts) With Advanced Renal Cell Carcinoma (RCC) Treated With Sunitinib and Sorafenib: Results From a Multi-country Study in Europe

✍ Oudard, S.; Porta, C.; Castellano, D.; McDermott, R.; Nathan, P.; McCaffrey, J.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB